ArticleEndocrine2020

Peptide receptor radionuclide therapy as a two-step strategy for initially unresectable liver disease from neuroendocrine tumors: a single-center experience.

Costanza Chiapponi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.